Le Figaro reports the tablet arrives in early November. Unlike the Wegovy injection, it won't be covered by France's public reimbursement system.
Recap by typeshit. Full story at MedWatch.
Monthly units climbed from 114,000 in February to 434,000 in September, and sales value rose from ₹48 cr to ₹113 cr as doctors report wider access.
A TV segment airing on WSIL and KFVS looks at the weight loss drug trend and what coverage people might be able to get through their insurance today.
Lilly is lowering what it charges for one of its weight loss drugs. The headline doesn't say which drug or by how much.
Access to Ozempic, Wegovy and Mounjaro in Australia often comes down to who can pay, raising the question of public subsidies.
An endocrinologist gives a general explainer on who these weight loss injections may suit and how they work, aimed at people with obesity or constant hunger.
She says certain foods prompt the gut to release GLP1 and PYY, which she credits with fullness and slower digestion. A recipe post, not drug news.
Loading…